Condition: Hypoxic Ischemic Encephalopathy of Newborn · Hyperglycemia · Hypoglycemia · Sponsor: University of Campania Luigi Vanvitelli
The aim of the study is to examine whether the use of continuous glucose monitoring (CGM) to guide the clinical management of glycaemic control will result into an increased time in the target glucose concentration. To further examine the efficacy of using CGM the following secondary outcomes in the two groups were assessed: mean glucose values, glucose variability within individuals, percentage of time that glucose values are in hyperglycaemic or hypoglycaemic ranges. Randomized controlled trial recruiting neonates (Birth weight \>1.8kg, Gestation\>36 weeks) with moderate or severe hypoxic ischemic encephalopathy (HIE) following perinatal asphyxia . Neonates will be randomly assigned (1:1) within 6 hours of birth to receive either the intervention with real-time CGM or standard care for 72 hours.
This description comes directly from the study's public registry record.
Paolo Montaldo, PhD · 0815664023 · paolo.montaldo@unicampania.it
Simona Puzone, MD · simona.puzone@unicampania.it
Always discuss trial participation with your own doctor first.
| A.O.S.G. Moscati | Avellino, Italy | Not Yet Recruiting |
| University of Campania Luigi Vanvitelli | Naples, Italy | Recruiting |
| Monaldi | | AORN - Ospedali dei ColliAORN - Ospedali dei Colli | Naples, Italy | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06563687